PSMD11-CCL15 Fusion FISH Probe
The PSMD11-CCL15 Fusion FISH Probe is used to confirm a fusion of the PSMD11 and CCL15 genes. The fusion of the PSMD11 and CCL15 genes has been associated with Cholangiocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| PSMD11-CCL15-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| PSMD11-CCL15-20-RERE | 20 (40 μL) | 200 μL |
|
|
| PSMD11-CCL15-20-REOR | 20 (40 μL) | 200 μL |
|
|
| PSMD11-CCL15-20-REGO | 20 (40 μL) | 200 μL |
|
|
| PSMD11-CCL15-20-REGR | 20 (40 μL) | 200 μL |
|
|
| PSMD11-CCL15-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| PSMD11-CCL15-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| PSMD11-CCL15-20-OROR | 20 (40 μL) | 200 μL |
|
|
| PSMD11-CCL15-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| PSMD11-CCL15-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| PSMD11-CCL15-20-GORE | 20 (40 μL) | 200 μL |
|
|
| PSMD11-CCL15-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| PSMD11-CCL15-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| PSMD11-CCL15-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| PSMD11-CCL15-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| PSMD11-CCL15-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| PSMD11-CCL15-20-GROR | 20 (40 μL) | 200 μL |
|
|
| PSMD11-CCL15-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| PSMD11-CCL15-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| PSMD11-CCL15-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| PSMD11-CCL15-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| PSMD11-CCL15-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| PSMD11-CCL15-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| PSMD11-CCL15-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| PSMD11-CCL15-20-AQAQ | 20 (40 μL) | 200 μL |
|
PSMD11 Gene Summary
The 26S proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator. The 20S core is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. The 19S regulator is composed of a base, which contains 6 ATPase subunits and 2 non-ATPase subunits, and a lid, which contains up to 10 non-ATPase subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. This gene encodes a member of the proteasome subunit S9 family that functions as a non-ATPase subunit of the 19S regulator and is phosphorylated by AMP-activated protein kinase. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Jul 2012]
Gene Name: Proteasome 26S Subunit, Non-ATPase 11
Chromosome: CHR17: 30771501 -30808042
Locus: 17q11.2
CCL15 Gene Summary
This gene is located in a cluster of similar genes in the same region of chromosome 17. These genes encode CC cytokines, which are secreted proteins characterized by two adjacent cysteines. The product of this gene is chemotactic for T cells and monocytes, and acts through C-C chemokine receptor type 1 (CCR1). The proprotein is further processed into numerous smaller functional peptides. Naturally-occurring readthrough transcripts occur from this gene into the downstream gene, CCL14 (chemokine (C-C motif) ligand 14). [provided by RefSeq, Jan 2013]
Gene Name: C-C Motif Chemokine Ligand 15
Chromosome: CHR17: 34324617 -34329084
Locus: 17q12
Gene Diseases
The PSMD11 CCL15 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Cholangiocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|